Profound Medical Corp Stock Statistic Functions Variance
| PROF Stock | USD 5.41 0.18 3.44% |
| Symbol |
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. Profound Medical Corp Variance is a measurement of the price spread between periods of Profound Medical price series.
Profound Medical Technical Analysis Modules
Most technical analysis of Profound Medical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Profound from various momentum indicators to cycle indicators. When you analyze Profound charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Profound Medical Corp
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada. Profound Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 146 people. This stock section frames Profound Medical within its peer set and highlights how fundamentals align with price behavior. Current metrics include P/B of 6.13, profit margin of -2.64%. Profound Medical has market cap of 196.34 M, ROE of -67.11%.
Methodology
Unless otherwise specified, financial data for Profound Medical Corp is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Profound (USA Stocks:PROF) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We primarily rely on public filings and market reference sources, including disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data is normalized for analytical consistency across reporting formats. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Profound Medical Corp may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Align your values with your investing style
Using Profound Medical Corp inside a theme workflow gives investors a structured way to compare related stocks, funds, ETFs, and crypto assets before allocating capital. The practical benefit is that the selected idea can be tuned either for higher upside or for tighter risk control.
Thematic Opportunities
Explore Investment Opportunities
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | Baby Boomer Prospects Invested over 60 shares | |
 | Hedge Favorites Invested few shares | |
 | Investor Favorites Invested over 200 shares | |
 | Momentum Invested over 40 shares | |
 | Driverless Cars Invested over 200 shares | |
 | Blockchain Invested few shares | |
 | Advertising Invested few shares | |
More Resources for Profound Stock Analysis
A comprehensive view of Profound Medical Corp starts with financial statements and ratio context. Ratios and trend metrics help frame Profound Medical's operating context. Highlighted below are reports that provide context for Profound Medical Corp Stock:Profound Medical has market cap of 196.34 M, operating margin of -123.29%, ROE of -67.11%. See Your Equity Center for portfolio-level analysis. This suggests a position in Profound Medical Corp inside the allocation mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. Analysis related to Profound Medical should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Earnings Share -1.32 | Revenue Per Share | Quarterly Revenue Growth 0.431 | Return On Assets | Return On Equity |
Understanding Profound Medical Corp includes distinguishing between market value and book value, where book value reflects Profound accounting equity. Profound Medical's market capitalization is 196.34 M. With a P/B ratio of 6.13, the market values Profound Medical well above its book equity. Enterprise value stands at 174.69 M. Intrinsic value is an estimate of what Profound Medical's fundamentals imply, and it may differ from market and book figures. Analytical frameworks help compare those viewpoints.
The concept of value for Profound Medical differs from its quoted price, since each reflects a different lens. For Profound Medical, key inputs include a P/B ratio of 6.13, a profit margin of -2.64%, ROE of -67.11%, and revenue of 16.1 M. Market price reflects the current exchange level formed by active bids and offers.